GALY utilizes cellular agriculture technology to produce cotton and other crops in controlled bioreactor environments, significantly reducing resource use by 80% while achieving 500 times the productivity of traditional farming. This method addresses the challenges of climate risk, deforestation, and pesticide use associated with conventional agriculture, providing a reliable and traceable supply chain.
Funding
$65M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BEFounders
Product
Problem
Conventional cotton farming faces increasing challenges due to climate change, including drought, floods, and wildfires, leading to unstable supply chains. Traditional agriculture also contributes to deforestation, misuse of agrochemicals, water waste, and unsafe working conditions. These factors create environmental and social concerns for brands and consumers seeking sustainable alternatives.
Solution
GALY utilizes cellular agriculture to produce cotton and other crops in controlled bioreactor environments, offering a sustainable and traceable alternative to traditional farming. This method significantly reduces resource consumption, including water, land, and agrochemicals, while also minimizing greenhouse gas emissions. By cultivating plant cells in a lab, GALY achieves higher productivity and predictable supply, independent of climate-related risks. The controlled environment allows for customizable quality and performance combinations tailored to specific client needs, ensuring a reliable and consistent product.
Target Audience
GALY's primary customers are brands in the fashion, textile, and materials industries seeking sustainable, traceable, and customizable cotton alternatives.
Features
- Patented cellular agriculture technology for in-vitro cotton production
- Cell isolation and seed train processes for identifying and cultivating ideal cell types
- Cryopreservation for maintaining cell lines and ensuring long-term viability
- Upstream processing in factory-scale bioreactors with optimized growth environments
- Downstream processing to transform cellular material into final products
- Customizable quality and performance parameters to meet specific client requirements
- Traceability throughout the production process, from cell isolation to final product
- Significant reduction in water, land, and agrochemical use compared to traditional farming